The Scientific Team at Epsilogen focuses on the research and development of immunoglobulin (IgE) antibodies for cancer treatment. Team members collaborate to design, engineer, and optimize potent IgE antibodies, leveraging their expertise in phage display, protein science, and advanced scientific methodologies to enhance tumour targeting and improve therapeutic efficacy.
View all